NDC 81033-032-01 - Mupirocin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-032
- Requested NDC
- 81033-032-01
- Package NDCs from labels
- 81033-032-01, 81033-032-50, 81033-032-99
- Manufacturer
- Kesin Pharma Corporation
- Effective date
- 2025-05-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mupirocin Ointment - Kesin Pharma Corporation | Kesin Pharma Corporation | 2025-05-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-032-01 | Mupirocin | 1 g in 1 TUBE | OINTMENT | 1 | 7 | |
| 81033-032-50 | Mupirocin | 50 in 1 BOX | OINTMENT | 50 | 7 | |
| 81033-032-99 | Mupirocin | 100 in 1 BOX | OINTMENT | 100 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-032-01 | GM - Gram | 81033-032 | bee79b6e-6f9e-40d7-861f-6b07462600b9 | 1 | 2025-06-13 |
| 81033-032-50 | GM - Gram | 81033-032 | c06a73cb-4436-4d1a-a85d-c11b32f9f744 | 1 | 2025-06-13 |
| 81033-032-99 | GM - Gram | 81033-032 | 72584aad-1ebd-45d0-a738-c191d702f88f | 1 | 2025-06-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| foster and thrive clearlax | POLYETHYLENE GLYCOL 3350 | Strategic Sourcing Services LLC | 684e35cc-5a4f-458d-b5e7-e1933fea1139 | 2026-03-07 | Warnings | G2M7P15E5P |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-03-06 | Warnings | B697894SGQ |
| ez2go Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Valley Medical Products, LLC | d64517d6-b0cc-4ba2-b260-e52faa8d4e78 | 2026-02-20 | Warnings | G2M7P15E5P |
| Topcare ClearLax | POLYETHYLENE GLYCOL 3350 | Topco Associates LLC | 03291fd3-7b64-4b79-ad84-e1b9b30a6b03 | 2026-02-19 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | American Health Packaging | 81374641-e54c-4b41-a3ad-49b19a097666 | 2026-02-18 | Warnings | G2M7P15E5P |
| GoodSense Eye Drops Advanced Relief Moisturizer | DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Sportpharm LLC | 8d58dcbb-72a0-41f0-9eeb-613072a6d7ae | 2026-02-06 | Warnings | B697894SGQ |
| MUPIROCIN | MUPIROCIN | Redpharm Drug | 49eb7289-c44d-75e1-e063-6294a90a2283 | 2026-02-03 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| mupirocin | MUPIROCIN | REMEDYREPACK INC. | 290b4e51-59b4-429a-987b-715ac817ef2c | 2026-01-28 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | GLENMARK THERAPEUTICS INC., USA | 5aba6bb1-d25d-4901-8e9c-4cd4a3a06471 | 2026-01-27 | Warnings | G2M7P15E5P |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | Preferred Pharmaceuticals Inc. | 935f05da-3637-4a9e-843e-1f2ced5d1a74 | 2026-01-23 | Warnings | G2M7P15E5P |
| Mupirocin | MUPIROCIN | AvPAK | 8b10c706-ae9c-fc76-e053-2a95a90a4c73 | 2026-01-20 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | YYBA Corp | 48488531-5d04-4af6-e063-6294a90afe4b | 2026-01-13 | Warnings | G2M7P15E5P |
| Lubricant Eye Drops Solution | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | AvPAK | f5743b38-e3d2-a065-e053-2995a90a4b9a | 2026-01-08 | Warnings | B697894SGQ |
| Value Health by Prodose Eye Drops | TETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 | Prodose, Inc. | 3fafa362-a8a6-3f91-e063-6394a90a98b3 | 2025-12-31 | Warnings | B697894SGQ |
| Signature Care Eye Drops High Performance | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Better Living Brands LLC | 6f1f4f58-3208-4b06-9afb-c4beeed09314 | 2025-12-30 | Warnings | B697894SGQ |
| Target Lubricant Eye Drops High Performance | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Target Corporation | 6c449374-8847-4c4a-9073-1951ff31d404 | 2025-12-30 | Warnings | B697894SGQ |
| Target Lubricant Eye Drops High Performance | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Target Corporation | ddc15dac-fbd8-42fa-80db-79f49fc6b9eb | 2025-12-30 | Warnings | B697894SGQ |
| CVS Advanced Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE | CVS Pharmacy, Inc. | f74a2fca-902c-f68a-e053-6394a90abb88 | 2025-12-30 | Warnings | B697894SGQ |
| CVS Hydration Eye Drops | POLYETYLENE GLYCOL 400, PROPYLENE GLYCOL | CVS | ecab8fa3-6575-0dde-e053-2a95a90abd61 | 2025-12-30 | Warnings | B697894SGQ |
| GoodSense Eye Drops Advanced Relief Moisturizer | DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Geiss, Derstin & Dunn, Inc. | 9b34de99-13df-201a-e053-2a95a90ae559 | 2025-12-30 | Warnings | B697894SGQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.